Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of Ariscat Risk Index In The Development of Postoperative Pulmonary Complication After Major Abdominal Cancer Surgery

NCT04663958 is registered in ClinicalTrials.gov with Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital as lead sponsor.

NCT NCT04663958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04663958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of Ariscat Risk Index In The Development of Postoperative Pulmonary Complication After Major Abdominal Cancer Surgery
Lead sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Phase
Observational
Overall status
Completed
Start date
December 21, 2020
Completion date
August 18, 2021
Enrollment
410 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal surgery, atelectasis, cancer, pneumonia, postoperative complications, pulmonary complication